180 related articles for article (PubMed ID: 25791835)
1. Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery system.
De Backer L; Braeckmans K; Stuart MC; Demeester J; De Smedt SC; Raemdonck K
J Control Release; 2015 May; 206():177-86. PubMed ID: 25791835
[TBL] [Abstract][Full Text] [Related]
2. Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophages.
De Backer L; Naessens T; De Koker S; Zagato E; Demeester J; Grooten J; De Smedt SC; Raemdonck K
J Control Release; 2015 Nov; 217():53-63. PubMed ID: 26307350
[TBL] [Abstract][Full Text] [Related]
3. Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy.
Merckx P; Lammens J; Nuytten G; Bogaert B; Guagliardo R; Maes T; Vervaet C; De Beer T; De Smedt SC; Raemdonck K
Eur J Pharm Biopharm; 2020 Dec; 157():191-199. PubMed ID: 33022391
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.
Merckx P; De Backer L; Van Hoecke L; Guagliardo R; Echaide M; Baatsen P; Olmeda B; Saelens X; Pérez-Gil J; De Smedt SC; Raemdonck K
Acta Biomater; 2018 Sep; 78():236-246. PubMed ID: 30118853
[TBL] [Abstract][Full Text] [Related]
5. The influence of natural pulmonary surfactant on the efficacy of siRNA-loaded dextran nanogels.
De Backer L; Braeckmans K; Demeester J; De Smedt SC; Raemdonck K
Nanomedicine (Lond); 2013 Oct; 8(10):1625-38. PubMed ID: 23418856
[TBL] [Abstract][Full Text] [Related]
6. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
7. Evaluating β
Merckx P; Conickx G; Blomme E; Maes T; Bracke KR; Brusselle G; De Smedt SC; Raemdonck K
Eur J Pharm Biopharm; 2024 Apr; 197():114223. PubMed ID: 38367760
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
Benfer M; Kissel T
Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
[TBL] [Abstract][Full Text] [Related]
10. PEGylation of biodegradable dextran nanogels for siRNA delivery.
Naeye B; Raemdonck K; Remaut K; Sproat B; Demeester J; De Smedt SC
Eur J Pharm Sci; 2010 Jul; 40(4):342-51. PubMed ID: 20435139
[TBL] [Abstract][Full Text] [Related]
11. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.
Qiu Y; Chow MYT; Liang W; Chung WWY; Mak JCW; Lam JKW
Mol Pharm; 2017 Dec; 14(12):4606-4617. PubMed ID: 29121767
[TBL] [Abstract][Full Text] [Related]
12. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
[TBL] [Abstract][Full Text] [Related]
13. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells.
Mimi H; Ho KM; Siu YS; Wu A; Li P
J Control Release; 2012 Feb; 158(1):123-30. PubMed ID: 22094103
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
[TBL] [Abstract][Full Text] [Related]
15. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional nanogels for siRNA delivery.
Smith MH; Lyon LA
Acc Chem Res; 2012 Jul; 45(7):985-93. PubMed ID: 22181582
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearance.
Zhang L; Xue H; Cao Z; Keefe A; Wang J; Jiang S
Biomaterials; 2011 Jul; 32(20):4604-8. PubMed ID: 21453965
[TBL] [Abstract][Full Text] [Related]
18. In situ preparation of gold nanoparticle-loaded lysozyme-dextran nanogels and applications for cell imaging and drug delivery.
Cai H; Yao P
Nanoscale; 2013 Apr; 5(7):2892-900. PubMed ID: 23447082
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins.
Guagliardo R; Pérez-Gil J; De Smedt S; Raemdonck K
J Control Release; 2018 Dec; 291():116-126. PubMed ID: 30321577
[TBL] [Abstract][Full Text] [Related]
20. Quaternized starch-based carrier for siRNA delivery: from cellular uptake to gene silencing.
Amar-Lewis E; Azagury A; Chintakunta R; Goldbart R; Traitel T; Prestwood J; Landesman-Milo D; Peer D; Kost J
J Control Release; 2014 Jul; 185():109-20. PubMed ID: 24794893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
